Audicin raises $1.9M to embed real-time nervous-system regulation into wearables and partner apps
Summary
Audicin announced raising $1.9 million in March 2026 to make real-time nervous-system regulation a built-in layer for wearables and partner apps. The company's technology uses audio-neural entrainment and biosignal processing to modulate autonomic nervous system state in real time, targeting the wearable and app ecosystem as a B2B embedded technology rather than building consumer devices directly. The licensing approach follows the same "Intel Inside" model as Neurable's OEM BCI platform and positions Audicin as infrastructure for the nervous-system regulation layer of next-generation wearables.
Why it matters
The idea of making nervous-system regulation a "built-in layer" for wearables — rather than a standalone device — is an elegant commercial strategy that leverages the distribution of existing wearable manufacturers. If Audicin can demonstrate that audio-based autonomic regulation improves wearable user outcomes, they can license this capability to Oura, WHOOP, Garmin, and Samsung without competing on hardware. The B2B licensing model generates recurring revenue proportional to partner device volume.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial